Patients not already receiving buprenorphine can receive the first injection of Sublocade following a single dose of transmucosal buprenorphine and a 1 hour observation period to confirm tolerability.

RICHMOND, Va., Oct. 15, 2025 /PRNewswire/ -- Indivior PLC (Nasdaq: INDV) this week published compelling results from a multicenter, open-label clinical trial published in JAMA Network Open. Two ...

PDUFA date set for February 7, 2025 If approved by the FDA, label would expand to include alternative injection sites in the thigh, buttock and back of the arm for induction and maintenance as well as ...

IN INFANTS and children the technic of induction of anesthesia demands careful consideration, if optimal results are to be obtained. The success of the induction depends upon several factors, one of ...

RICHMOND - Indivior PLC (NASDAQ:INDV), a pharmaceutical company with a market capitalization of $3.1 billion and an impressive 207% return over the past year, announced Wednesday that a new clinical ...